106 related articles for article (PubMed ID: 32705204)
1. Cucurbitacin I induces apoptosis in ovarian cancer cells through oxidative stress and the p190B‑Rac1 signaling axis.
Li R; Xiao J; Tang S; Lin X; Xu H; Han B; Yang M; Liu F
Mol Med Rep; 2020 Sep; 22(3):2545-2550. PubMed ID: 32705204
[TBL] [Abstract][Full Text] [Related]
2. Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.
El-Senduny FF; Badria FA; El-Waseef AM; Chauhan SC; Halaweish F
Tumour Biol; 2016 Jan; 37(1):685-98. PubMed ID: 26242260
[TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of cucurbitacin-A in ovarian cancer cell line SKOV3 involves cell cycle arrest, apoptosis and inhibition of mTOR/PI3K/Akt signaling pathway.
Liu J; Liu X; Ma W; Kou W; Li C; Zhao J
J BUON; 2018; 23(1):124-128. PubMed ID: 29552771
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
Ishii T; Kira N; Yoshida T; Narahara H
Tumour Biol; 2013 Feb; 34(1):285-91. PubMed ID: 23150173
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway.
Ni Y; Wu S; Wang X; Zhu G; Chen X; Ding Y; Jiang W
J Cell Biochem; 2018 Jul; 119(7):6104-6112. PubMed ID: 29575175
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin I Protects H9c2 Cardiomyoblasts against H
Yang DK; Kim SJ
Oxid Med Cell Longev; 2018; 2018():3016382. PubMed ID: 29682157
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin D impedes gastric cancer cell survival via activation of the iNOS/NO and inhibition of the Akt signalling pathway.
Zhang YZ; Wang CF; Zhang LF
Oncol Rep; 2018 Jun; 39(6):2595-2603. PubMed ID: 29658590
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacin B induces mitochondrial-mediated apoptosis pathway in cholangiocarcinoma cells via suppressing focal adhesion kinase signaling.
Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
Naunyn Schmiedebergs Arch Pharmacol; 2019 Mar; 392(3):271-278. PubMed ID: 30470919
[TBL] [Abstract][Full Text] [Related]
11. Cucurbitacin-I induces hypertrophy in H9c2 cardiomyoblasts through activation of autophagy via MEK/ERK1/2 signaling pathway.
Wu Y; Chen H; Li R; Wang X; Li H; Xin J; Liu Z; Wu S; Jiang W; Zhu L
Toxicol Lett; 2016 Dec; 264():87-98. PubMed ID: 27836799
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells.
Premkumar DR; Jane EP; Pollack IF
Cancer Biol Ther; 2015; 16(2):233-43. PubMed ID: 25482928
[TBL] [Abstract][Full Text] [Related]
13. Sestrin-3 modulation is essential for therapeutic efficacy of cucurbitacin B in lung cancer cells.
Khan N; Jajeh F; Khan MI; Mukhtar E; Shabana SM; Mukhtar H
Carcinogenesis; 2017 Feb; 38(2):184-195. PubMed ID: 27881463
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN.
Shang Y; Guo XX; Li WW; Rao W; Chen ML; Mu LN; Li SJ
Eur Rev Med Pharmacol Sci; 2014; 18(21):3297-303. PubMed ID: 25487942
[TBL] [Abstract][Full Text] [Related]
15. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer.
Kim HJ; Park JH; Kim JK
Chem Biol Interact; 2014 Aug; 219():1-8. PubMed ID: 24858077
[TBL] [Abstract][Full Text] [Related]
17. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway.
Zhang L; Liang H; Xin Y
Anticancer Drugs; 2020 Sep; 31(8):847-855. PubMed ID: 32568828
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.
Sikander M; Hafeez BB; Malik S; Alsayari A; Halaweish FT; Yallapu MM; Chauhan SC; Jaggi M
Sci Rep; 2016 Nov; 6():36594. PubMed ID: 27824155
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis.
Zhang T; Li Y; Park KA; Byun HS; Won M; Jeon J; Lee Y; Seok JH; Choi SW; Lee SH; Man Kim J; Lee JH; Son CG; Lee ZW; Shen HM; Hur GM
Autophagy; 2012 Apr; 8(4):559-76. PubMed ID: 22441021
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer.
Liu P; Xiang Y; Liu X; Zhang T; Yang R; Chen S; Xu L; Yu Q; Zhao H; Zhang L; Liu Y; Si Y
Molecules; 2019 Feb; 24(3):. PubMed ID: 30759826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
